Present Positions

• Chief Medical Advisor — Republic of South Africa Medical Marijuana Dispensaries (RSAMMD)
• Chief Executive Officer & Director — TruLeaf Health
• Acting Medical Manager — Mediclinic Newcastle
• Specialist Anesthesiologist — Mediclinic Newcastle
• Member of the Board of Directors — Mediclinic Newcastle
• Chairperson — Hospital Performance Committee
• Chairperson — COVID Task Team
• Certified Cannabis Physician
• American Board-Certified Anesthesiologist
• HPCSA Registered Specialist Anesthesiologist

Executive Profile

Dr. Regina S. Hurley is an American Board-Certified Anesthesiologist, Cannabis Physician, Medical Educator, Global Medicinal Cannabis Advocate, and Healthcare Executive recognized for operating at the intersection of:

• Clinical Medicine
• Pharmacology
• Cannabinoid Science
• Patient Advocacy
• Advanced Plant-Based Therapeutics

As Chief Medical Advisor for RSAMMD and Chief Executive Officer & Director of TruLeaf Health, Dr. Hurley plays a strategic leadership role in the advancement of:

• Plant-Based Medicinal Science
• High-Bioavailability Cannabinoid Formulations
• Nanotechnology-Enhanced Delivery Systems
• Global Patient Access Initiatives

With more than two decades of experience in:

• Anesthesiology
• Critical Care
• Pharmacology
• Clinical Education
• Hospital Governance

She combines extensive hospital leadership experience with a deep understanding of:

• Human Physiology
• Pain Management
• Cannabinoid Therapeutics
• Patient-Centered Care

Her work reflects a long-standing commitment to advancing scientifically validated plant-based medicine while improving patient accessibility, clinical education, and global healthcare outcomes.

Medical Foundation & Clinical Leadership

Dr. Hurley completed extensive specialist training in anesthesiology through:

• Jackson Memorial Hospital
• Miami Children’s Hospital

Including advanced specialization through a Fellowship in Pediatric Cardiac Anesthesiology.

She has maintained active medical licensure in:

• Florida
• Texas
• South Africa (HPCSA Registered)

Her clinical expertise spans:

• General Anesthesia
• Pediatric Cardiac Anesthesia
• Critical Care
• Pain Management
• Advanced Pharmacology
• Perioperative Medicine
• Hospital Management

In South Africa, she served for approximately 12 years within the public healthcare system, including:

• Head of Department — Amajuba District
• Director — Diploma in Anesthesia Program

Through these leadership roles, she helped train and mentor numerous junior doctors who later advanced into specialist anesthesiology and broader medical leadership positions.

Her dedication to medical education, clinical excellence, and healthcare development has contributed significantly toward strengthening anesthesiology training and perioperative care standards within South Africa.

Hospital Governance & Healthcare Operations

Dr. Hurley continues to provide specialized anesthesia services through her work at Mediclinic Newcastle, where she serves in multiple executive and governance leadership roles.

Her responsibilities have included:

• Acting Medical Manager
• Board of Directors Participation
• Hospital Performance Oversight
• COVID Response Leadership
• Patient Safety & Quality Control
• Multi-Disciplinary Medical Coordination

Her leadership reflects a strong emphasis on:

• Clinical Excellence
• Patient Outcomes
• Medical Ethics
• Healthcare Accessibility
• Continuous Professional Education

During the global COVID-19 pandemic, Dr. Hurley played an active leadership role in hospital coordination and response initiatives, helping guide operational continuity, patient management strategies, and healthcare team collaboration during a period of unprecedented healthcare pressure.

RSAMMD & Medical Cannabis Leadership

As Chief Medical Advisor for RSAMMD, Dr. Hurley plays a leading role in helping guide the organization’s medical, scientific, and patient-centered initiatives involving medicinal cannabis, cannabinoid research, and plant-based therapeutic development.

Her responsibilities include contributing toward:

• Medical Governance
• Clinical Education
• Cannabinoid Research Initiatives
• Physician & Patient Education
• Regulatory Compliance
• Scientific Validation Strategies
• Patient Safety Protocols
• Advanced Cannabinoid Formulation Development

Through RSAMMD, Dr. Hurley has helped support initiatives focused on:

• Medical Cannabis Accessibility
• Scientifically Validated Cannabinoid Applications
• Pharmaceutical-Grade Cannabinoid Development
• Non-Opioid Pain Management Strategies
• Education for Healthcare Professionals
• Responsible Industry Development

Her role bridges:

• Clinical Medicine
• Cannabinoid Pharmacology
• Patient Advocacy
• Scientific Research
• Regulatory Frameworks

Into a medically driven platform focused on improving patient outcomes and advancing global understanding of cannabinoid therapeutics.

Global Medicinal Cannabis Advocacy & Scientific Education

As a Certified Cannabis Physician and Chief Medical Advisor for RSAMMD, Dr. Hurley has become one of the leading advocates for scientifically grounded medicinal cannabis education in South Africa and internationally.

In 2018, she delivered one of the first HPCSA-approved Continuing Professional Development (CPD) lectures focused on:

“The Science of Medicinal Cannabis”

Her educational and advocacy efforts have focused on:

• Cannabinoid Pharmacology
• Pain Management Applications
• Neurological Conditions
• Inflammatory Disorders
• Patient Safety Protocols
• Evidence-Based Cannabis Therapeutics

She has served as a lecturer and speaker at:

• The Cannabis Expo
• African Hemp Summit
• Medical Education Programs
• Global Cannabis Industry Events

Dr. Hurley has also received international recognition for her work, including media features on CNN as an official hemp researcher.

Clinical Research, SAHPRA Ethics & Cannabinoid Pain Studies

Dr. Hurley has played a significant role in the advancement of clinical cannabinoid research focused on investigating cannabinoid-based therapeutics as a potential alternative or adjunct to opioid-based treatments in chronic pain management.

She has been directly involved in helping oversee:

• Clinical Governance
• Medical Oversight
• Patient Safety Protocols
• Ethics Compliance Structures
• SAHPRA-Aligned Regulatory Frameworks
• Cannabinoid Therapeutic Evaluation

The research initiatives focus on evaluating:

• Cannabinoids in Chronic Pain Management
• Non-Opioid Treatment Strategies
• Patient Quality of Life Outcomes
• Opioid-Sparing Therapeutic Approaches
• Advanced Cannabinoid Formulations
• Evidence-Based Cannabinoid Medicine

TruLeaf Health & Advanced Cannabinoid Innovation

As Chief Executive Officer & Director of TruLeaf Health, Dr. Hurley oversees initiatives focused on:

• High-Bioavailability CBD Formulations
• Nanotechnology-Enhanced Delivery Systems
• Plant-Based Wellness Products
• Nutraceutical Development
• Patient Accessibility
• Global Commercialization Strategies

Her leadership reflects a broader vision of combining science, technology, and natural medicine into scalable wellness platforms capable of serving global patient populations.

Pharmacology, Physiology & Cannabinoid Science

Dr. Hurley’s background in anesthesiology provides a uniquely advanced understanding of:

• Human Physiology
• Receptor Systems
• Neurochemistry
• Pain Pathways
• Drug Interactions
• Pharmacokinetics
• Pharmacodynamics

Her scientific focus includes:

• The Endocannabinoid System
• Non-Opioid Pain Management Strategies
• Cannabinoid Safety Profiles
• High-Bioavailability Delivery Methods
• Patient-Specific Therapeutic Approaches

Vision & Philosophy

Dr. Hurley’s philosophy is centered on the belief that true healthcare innovation must combine:

• Science
• Compassion
• Education
• Accessibility
• Patient Safety
• Global Collaboration

Her long-term vision focuses on helping create a world where:

• Safe medicinal cannabis is globally accessible
• Patients have affordable treatment options
• Plant-based medicine is scientifically validated
• Healthcare education continues to evolve
• Technology supports human well-being

Her guiding objective remains:

“Affordable and safe medicinal cannabis to all patients worldwide.”

Summary

Dr. Regina S. Hurley stands as a multidisciplinary global healthcare leader integrating:

• Medicine
• Anesthesiology
• Pharmacology
• Cannabinoid Science
• Medical Education
• Biotechnology
• Patient Advocacy

Into a unified platform focused on advancing human health, scientific education, and global access to safe plant-based therapeutics.

Through RSAMMD, TruLeaf Health, and affiliated initiatives, she continues helping shape the future of:

• Medicinal Cannabis
• Clinical Cannabinoid Research
• High-Bioavailability Cannabinoid Formulations
• Patient-Centered Healthcare
• Plant-Based Pharmaceutical Development
• Global Wellness Innovation

Her mission remains centered on:

Patient Safety
Scientific Education
Global Healthcare Access
Plant-Based Medicine
Human Well-Being